Early research (Phase 1)Not Yet RecruitingNCT06749795What this trial is testingLIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis (UC) Liveome Inc. 15
Testing effectiveness (Phase 2)Study completedNCT06001177What this trial is testingEfficacy, Safety, and Tolerability of KAN-101 in People With Celiac DiseaseWho this might be right forCeliac DiseaseCoeliac Disease Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA 55
Testing effectiveness (Phase 2)Ended earlyNCT04065841What this trial is testingEfficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.Who this might be right forNon Alcoholic Steatohepatitis (NASH) Novartis Pharmaceuticals 234
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07750041What this trial is testingA Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal CancerWho this might be right forUnresectable Advanced or Metastatic Colorectal Cancer CSPC Megalith Biopharmaceutical Co.,Ltd. 260
Testing effectiveness (Phase 2)Study completedNCT03760003What this trial is testingDose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative ColitisWho this might be right forUlcerative Colitis Abivax S.A. 355
Large-scale testing (Phase 3)Looking for participantsNCT07595003What this trial is testingEfficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary DyskinesiaWho this might be right forChronic CholecystitisBiliary Dyskinesia Valenta Pharm JSC 300
Testing effectiveness (Phase 2)Study completedNCT03421431What this trial is testingAssess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic SteatohepatitisWho this might be right forNon-Alcoholic Steatohepatitis Enanta Pharmaceuticals, Inc 134
Testing effectiveness (Phase 2)Study completedNCT01028495What this trial is testingA Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer Rexahn Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT01465529What this trial is testingA Cross-over Study of OligoG in Subjects With Cystic Fibrosis. FibrosisWho this might be right forCystic Fibrosis AlgiPharma AS 26
Early research (Phase 1)UnknownNCT05989724What this trial is testingA First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorBreast CancerPancreatic Cancer+2 more Qurgen Inc. 150
Early research (Phase 1)Active Not RecruitingNCT03132922What this trial is testingMAGE-A4ᶜ¹º³²T for Multi-TumorWho this might be right forUrinary Bladder CancerMelanomaHead and Neck Cancer+7 more USWM CT, LLC 71
Early research (Phase 1)UnknownNCT06296095What this trial is testingTo Evaluate the Clinical Study of CUD005 Injection in Patients With CirrhosisWho this might be right forCirrhosis, Liver Anhui Provincial Hospital 9
Testing effectiveness (Phase 2)Ended earlyNCT03269695What this trial is testingEfficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.Who this might be right forUlcerative Colitis Pfizer 20
Post-approval studies (Phase 4)Looking for participantsNCT07681076What this trial is testingStudy to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy VolunteersWho this might be right forHealthy Volunteers Karuna Therapeutics, Inc., a Bristol Myers Squibb company 225
Not applicableEnded earlyNCT01250743What this trial is testingA Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis CWho this might be right forHepatitis C Health Innovations, Frontier Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT06750276What this trial is testingEvaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.Who this might be right forLiver FibrosisHepatic Cirrhosis AstraZeneca 40
Early research (Phase 1)Looking for participantsNCT06455280What this trial is testingSIPLIZUMAB in AILD and LT PatientsWho this might be right forAutoimmune Liver DiseaseLiver Transplant DisorderAutoimmune Hepatitis+3 more Elizabeth C. Verna 8
Early research (Phase 1)Study completedNCT06308874What this trial is testingInvestigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy FemalesWho this might be right forNon-alcoholic Steatohepatitis J2H Biotech 16
Early research (Phase 1)Study completedNCT02956850What this trial is testingA Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531Who this might be right forHepatitis B, Chronic Hoffmann-La Roche 160
Testing effectiveness (Phase 2)Ended earlyNCT05900050What this trial is testingEfficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®Who this might be right forAcute-On-Chronic Liver FailureAscites Genfit 15